Tag: biotechnology
-

FDA Halts Off-the-Shelf Engineered T-Cell Trial
A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple myeloma when a patient in the trial died.
-

Dual Antibodies in Trial to Prevent Covid-19 Infections
A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infections, while also in a trial as a treatment for the disease.
-

Biotech IDs Potent Covid-19 Antibodies
A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizing SARS-CoV-2 viruses causing Covid-19 infections.
-

Crispr Heart Therapy Demonstrated in Monkeys
An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease.
-

Trial to Test Stem Cells for Covid-19 Prevention
A company that collects and stores a person’s own stem cells for therapies later on says FDA cleared a clinical trial of donated stem cells to prevent Covid-19 infections.
-

Gene, Cell Therapy Start-Up Gains $700M in Early Funds
A biotechnology company creating engineered cells with modified genes for treating disease is raising $700 million in its first venture finance round.
-

Gut Microbe Drug Shown to Prevent Return Infections
Early results from a clinical trial show an oral drug taken one time prevents more recurring infections from harmful gut bacteria than conventional treatments.
-

Engineered Immune, Stem Cells Studied for HIV Cure
Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections.
-

Biotechs Partner on Crispr for Stem Cell Transplants
A biotechnology partnership is evaluating a synthetic antibody to make it safer for people with genetic diseases to receive gene-edited bone marrow stem-cell transplants.
-

Covid-19 Antibody Cocktail to Begin Clinical Trial
A combination of two synthetic antibodies, with an enhanced infection-blocking design for preventing and treating Covid-19 infections, is set to begin a clinical trial.